Sponsored
U.S. and Japan Lead Innovation in Gastrointestinal Oncology
The global esophageal cancer market is forecast to grow from USD 6.2 billion in 2023 to USD 11.1 billion by 2031, at a compound annual growth rate (CAGR) of 7.5% during the forecast period. This growth is primarily driven by the rising global incidence of esophageal adenocarcinoma and squamous cell carcinoma, along with advancements in targeted therapies, immunotherapies, and precision...
0 Comments 0 Shares 53 Views 0 Reviews
Sponsored
Sponsored
Sponsored